BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19456279)

  • 21. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiating COPD from asthma in clinical practice.
    Mosenifar Z
    Postgrad Med; 2009 May; 121(3):105-12. PubMed ID: 19491547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Living conditions for people with COPD].
    Hem KG; Eide AH
    Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1465-8. PubMed ID: 19690596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158).
    Li NG; Tang YP; Duan JA
    Expert Opin Ther Pat; 2013 May; 23(5):669-75. PubMed ID: 23506002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma and COPD: definitions, epidemiology, and treatment guidelines.
    Berger WE; Cline DC
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):2-8. PubMed ID: 19667710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel pharmacological approaches to airway and pulmonary vascular disease.
    Page C; MacLean M
    Curr Opin Pharmacol; 2009 Jun; 9(3):229-30. PubMed ID: 19442583
    [No Abstract]   [Full Text] [Related]  

  • 29. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical approaches to treating acute bronchospasm.
    Cline DC
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):9-17. PubMed ID: 19667711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The overlap syndrome of asthma and COPD: what are its features and how important is it?
    Gibson PG; Simpson JL
    Thorax; 2009 Aug; 64(8):728-35. PubMed ID: 19638566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of cathepsin C (dipeptidyl peptidase I).
    Laine DI; Busch-Petersen J
    Expert Opin Ther Pat; 2010 Apr; 20(4):497-506. PubMed ID: 20205619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wheezy patient with heart failure and chronic obstructive pulmonary disease: what to treat with?
    Palaniswamy C; Guleria R; Mohan A; Selvaraj DR
    Am J Emerg Med; 2008 Nov; 26(9):1060. PubMed ID: 19091275
    [No Abstract]   [Full Text] [Related]  

  • 34. LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.
    Binker MG; Binker-Cosen AA; Richards D; Oliver B; Cosen-Binker LI
    Biochem Biophys Res Commun; 2009 Aug; 386(1):124-9. PubMed ID: 19501047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics and reduced risk of COPD re-exacerbations.
    Antoniu SA
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):309-11. PubMed ID: 19670990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inferon clinicoimmunological efficacy in chronic obstructive pulmonary disease].
    Farkhutdinov UR; Farkhutdinov ShU; Abdrakhmanova LM
    Ter Arkh; 2009; 81(3):23-8. PubMed ID: 19459417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs.
    Ando N; Terashima S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4495-9. PubMed ID: 17574851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of 1-fluoro-4-methyl-9H-[carbonyl-(14) C]thioxanthen-9-one and amine derivatives.
    Javaheri M; Shirvani G; Amini M; Saemian N; Saadatjoo N
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):322-4. PubMed ID: 27157134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.